7473 related articles for article (PubMed ID: 1729312)
1. MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma.
Lucignani G; Paganelli G; Modorati G; Pieralli S; Rizzo G; Magnani P; Colombo F; Zito F; Landoni C; Scotti G
J Comput Assist Tomogr; 1992; 16(1):77-83. PubMed ID: 1729312
[TBL] [Abstract][Full Text] [Related]
2. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
[TBL] [Abstract][Full Text] [Related]
3. Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging.
Beyer T; Pietrzyk U; Knoess C; Vollmar S; Wienhard K; Kracht L; Bockisch A; Maderwald S; Kühl H; Fitzek M
Nuklearmedizin; 2008; 47(2):73-9. PubMed ID: 18392316
[TBL] [Abstract][Full Text] [Related]
4. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism and pathological findings in uveal melanoma: preliminary results.
Modorati G; Lucignani G; Landoni C; Freschi M; Trabucchi G; Fazio F; Brancato R
Nucl Med Commun; 1996 Dec; 17(12):1052-6. PubMed ID: 9004302
[TBL] [Abstract][Full Text] [Related]
6. Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma.
Schaling DF; Oosterhuis JA; Jager MJ; Kakebeeke-Kemme H; Pauwels EK
Br J Ophthalmol; 1994 Apr; 78(4):244-8. PubMed ID: 8199106
[TBL] [Abstract][Full Text] [Related]
7. [Values and limitations of radioimmunoscintigraphy with MoAb 225-28S in the diagnosis of posterior uveal melanoma].
Cavazza S; Tassoni A; Abbati A
J Fr Ophtalmol; 1992; 15(6-7):395-9. PubMed ID: 1294595
[TBL] [Abstract][Full Text] [Related]
8. Uveal melanoma, choroidal hemangioma, and simulating lesions. Role of MR imaging.
Mafee MF
Radiol Clin North Am; 1998 Nov; 36(6):1083-99, x. PubMed ID: 9884690
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.
Bomanji J; Hungerford JL; Granowska M; Britton KE
Br J Ophthalmol; 1987 Sep; 71(9):651-8. PubMed ID: 2822079
[TBL] [Abstract][Full Text] [Related]
10. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma and similar lesions: the role of magnetic resonance imaging and computed tomography.
Peyman GA; Mafee MF
Radiol Clin North Am; 1987 May; 25(3):471-86. PubMed ID: 3554332
[TBL] [Abstract][Full Text] [Related]
12. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma.
Magnani P; Paganelli G; Modorati G; Zito F; Songini C; Sudati F; Koch P; Maecke HR; Brancato R; Siccardi AG; Fazio F
J Nucl Med; 1996 Jun; 37(6):967-71. PubMed ID: 8683323
[TBL] [Abstract][Full Text] [Related]
13. Immunoimaging of choroidal melanoma: assessment of its diagnostic accuracy and limitations in 101 cases.
Scheidler J; Leinsinger G; Kirsch CM; Scheiffarth OF; Stefani FH; Riedel KG
Br J Ophthalmol; 1992 Aug; 76(8):457-60. PubMed ID: 1390525
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging in the evaluation and differentiation of uveal melanoma.
Mafee MF; Peyman GA; Peace JH; Cohen SB; Mitchell MW
Ophthalmology; 1987 Apr; 94(4):341-8. PubMed ID: 3587915
[TBL] [Abstract][Full Text] [Related]
15. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
16. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
[TBL] [Abstract][Full Text] [Related]
17. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
18. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance imaging in the evaluation of malignant melanoma of the choroid and ciliary body].
Bossard D; Grange JD; Froment JC; Gerard JP; Lyonnet D
Bull Soc Ophtalmol Fr; 1990; 90(8-9):865-7. PubMed ID: 2257671
[TBL] [Abstract][Full Text] [Related]
20. Value of positron emission tomography in the diagnosis of malignant ocular tumors.
Spraul CW; Lang GE; Lang GK
Ophthalmologica; 2001; 215(3):163-8. PubMed ID: 11340384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
